• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CG3:GR

93.988 EUR 1.980 2.06%

As of 10:30:38 ET on 12/22/2014.

Snapshot for Celgene Corp (CG3)

Open: 96.325 Day's Range: 90.279 - 96.500 Volume: 1,858
Previous Close: 95.968 52wk Range: 48.553 - 98.000 1-Yr Rtn: +53.61%

Stock Chart for CG3

No chart data available.
  • CG3:GR 94.810
  • 1D
  • 1M
  • 1Y
95.968
Interactive CG3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CG3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 31.7739
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 3.6920
Est. PEG Ratio 1.2319
Market Cap (M EUR) 76,404.84
Shares Outstanding (M) 798.70
30 Day Average Volume 3,051
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CG3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CG3

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Robert J Hugin "Bob"Chairman/CEOMark J AllesPresident/COO
Peter N KelloggExec VP/CFOThomas O DanielExec VP/Pres:Research
More Company Profile & Key Executives for CG3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil